Supplementary material for the manuscript "Rapid and sustained improvements in GPPGA scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled

NIAID Data Ecosystem60

Supplementary Material for: Participant heterogeneity of psoriasis interventional trials

银屑病临床试验

参与者分析

Introduction: Participant heterogeneity as a part of clinical heterogeneity has been proved to alter the intervention efficacy, however, factors associated with participant heterogeneity in psoriasis

DataCite Commons2025-09-22 更新30

Dataset from A Phase 2/3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Efficacy and Safety of Adalimumab in Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

银屑病临床试验

阿达木单抗疗效评估

The purpose of the study is to assess the efficacy and safety of repeated administration of adalimumab in adult Japanese subjects with moderate to severe chronic plaque psoriasis.

NIAID Data Ecosystem00

Dataset from A Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Trial Evaluating the Efficacy and Safety of Ustekinumab (CNTO 1275) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis

资源简介：

Dataset from A Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Trial Evaluating the Efficacy and Safety of Ustekinumab (CNTO 1275) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis

资源简介：

相关数据集